Molecular forms of prostate-specific antigen and human kallikrein 2 (hK2) in urine are not clinically useful for early detection and staging of prostate cancer

By Pannek J.   Rittenhouse H.G.   Evans C.L.   Finlay J.A.   Bruzek D.J.   Cox J.L.   Chan D.W.   Subong E.N.P.   Partin A.W.  

Urology, Vol. 50, Iss. 5, 1997-11 ,pp. : 715-721

Elsevier

Access to resources Recommend Favorite

Prostate-specific antigen, its molecular forms, and other kallikrein markers for detection of prostate cancer

By Stephan C.   Jung K.   Diamandis E.P.   Rittenhouse H.G.   Lein M.   Loening S.A.  

Urology, Vol. 59, Iss. 1, 2002-01 ,pp. : 2-8

Elsevier

Access to resources Recommend Favorite

Structural comparison of prostate-specific antigen and human glandular kallikrein using molecular modeling

By Bridon D.P.   Dowell B.L.  

Urology, Vol. 45, Iss. 5, 1995-05 ,pp. : 801-806

Elsevier

Access to resources Recommend Favorite

Detection of a prostate-specific protein, human glandular kallikrein (hK2), in sera of patients with elevated prostate-specific antigen levels

By Charlesworth M.C.   Young C.Y.-F.   Klee G.G.   Saedi M.S.   Mikolajczyk S.D.   Finlay J.A.   Tindall D.J.  

Urology, Vol. 49, Iss. 3, 1997-05 ,pp. : 487-493

Elsevier

Access to resources Recommend Favorite

Polyclonal and monoclonal antibodies to prostate-specific antigen can cross-react with human kallikrein 2 and human kallikrein 1 - a quantitative assessment

By Finlay J.A.   Day J.R.   Rittenhouse H.G.  

Urology, Vol. 53, Iss. 4, 1999-04 ,pp. : 746-751

Elsevier

Access to resources Recommend Favorite